Mark Hlatky, MD

Publications

• Association of coronary CT angiography or stress testing with subsequent utilization and spending among Medicare beneficiaries. Shreibati JB, Baker LC, Hlatky MA. JAMA. 2011; 306 (19): 2128-36
• Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Lee KK, Cipriano LE, Owens DK, Go AS, Hlatky MA. Circulation. 2010; 122 (15): 1478-87
• Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Lancet. 2009; 373 (9670): 1190-7
• Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC, Wilson PW. Circulation. 2009; 119 (17): 2408-16
• Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Hlatky MA, Boothroyd DB, Melsop KA, Kennedy L, Rihal C, Rogers WJ, Venkitachalam L, Brooks MM. Circulation. 2009; 120 (25): 2550-8
• Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Go AS, Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous T, Hlatky MA. Ann Intern Med. 2006; 144 (4): 229-38
• Cost-effectiveness of implantable cardioverter-defibrillators. Sanders GD, Hlatky MA, Owens DK. N Engl J Med. 2005; 353 (14): 1471-80
• Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Hlatky MA, Boothroyd DB, Melsop KA, Brooks MM, Mark DB, Pitt B, Reeder GS, Rogers WJ, Ryan TJ, Whitlow PL, Wiens RD. Circulation. 2004; 110 (14): 1960-6
• Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial. Barnett PG, Chen S, Boden WE, Chow B, Every NR, Lavori PW, Hlatky MA. Circulation. 2002; 105 (6): 680-4
• Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. JAMA. 2002; 287 (5): 591-7
• Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. Selby JV, Fireman BH, Lundstrom RJ, Swain BE, Truman AF, Wong CC, Froelicher ES, Barron HV, Hlatky MA. N Engl J Med. 1996; 335 (25): 1888-96
• Job strain and the prevalence and outcome of coronary artery disease. Hlatky MA, Lam LC, Lee KL, Clapp-Channing NE, Williams RB, Pryor DB, Califf RM, Mark DB. Circulation. 1995; 92 (3): 327-33
• The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. Mason JJ, Owens DK, Harris RA, Cooke JP, Hlatky MA. JAMA. 1995; 273 (24): 1919-25
• Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing NE. N Engl J Med. 1994; 331 (17): 1130-5
• A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. Am J Cardiol. 1989; 64 (10): 651-4
• Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. Hlatky MA, Califf RM, Harrell FE, Lee KL, Mark DB, Pryor DB. J Am Coll Cardiol. 1988; 11 (2): 237-45
• Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Hlatky MA, Pryor DB, Harrell FE, Califf RM, Mark DB, Rosati RA. Am J Med. 1984; 77 (1): 64-71
• Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. Chang TI, Leong TK, Kazi DS, Lee HS, Hlatky MA, Go AS. Am Heart J. 2013; 165 (5): 800-808.e2
• Effectiveness is the key to cost-effectiveness. Hlatky MA, Circulation. 2013; 127 (7): 764-5
• Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease. Chang TI, Yang J, Freeman JV, Hlatky MA, Go AS. J Card Fail. 2013; 19 (3): 176-82
• Epidemiologic and statistical methods for comparative effectiveness research. Hlatky MA, Winkelmayer WC, Setoguchi S. Heart Fail Clin. 2013; 9 (1): 29-36
• Late diagnosis of abdominal aortic aneurysms substantiates underutilization of abdominal aortic aneurysm screening for Medicare beneficiaries. Mell MW, Hlatky MA, Shreibati JB, Dalman RL, Baker LC. J Vasc Surg. 2013
• Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. Hlatky MA, Solomon MD, Shilane D, Leong TK, Brindis R, Go AS. J Am Coll Cardiol. 2013; 61 (3): 295-301
• Volume, outcome, and policy. Hlatky MA, J Interv Card Electrophysiol. 2013; 36 (2): 151-5
• Compelling evidence for coronary-bypass surgery in patients with diabetes. Hlatky MA, N Engl J Med. 2012; 367 (25): 2437-8
• Cost-effectiveness of transcatheter aortic valve replacement. Hlatky MA, Simons CT. Circulation. 2012; 125 (9): 1076-7
• Framework for evaluating novel risk markers. Hlatky MA, Ann Intern Med. 2012; 156 (6): 468-9
• Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. Hlatky MA, Douglas PS, Cook NL, Wells B, Benjamin EJ, Dickersin K, Goff DC, Hirsch AT, Hylek EM, Peterson ED, Roger VL, Selby JV, Udelson JE, Lauer MS. J Am Coll Cardiol. 2012; 60 (7): 569-80
• Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC. J Am Soc Nephrol. 2012; 23 (12): 2042-9
• Physician procedure volume and complications of cardioverter-defibrillator implantation. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. Circulation. 2012; 125 (1): 57-64
• Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. J Am Coll Cardiol. 2012; 59 (2): 143-9
• Repeat revascularization is a faulty end point for clinical trials. Kazi DS, Hlatky MA. Circ Cardiovasc Qual Outcomes. 2012; 5 (3): 249-50
• Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC. Circulation. 2012; 126 (19): 2293-301
• Vascular surgery patients prescribed preoperative β-blockers experienced a decrease in the maximal heart rate observed during induction of general anesthesia. Mudumbai SC, Wagner T, Mahajan S, King R, Heidenreich PA, Hlatky M, Wallace A, Mariano ER. J Cardiothorac Vasc Anesth. 2012; 26 (3): 414-9
• Cost-effectiveness of genetic testing in family members of patients with long-QT syndrome. Perez MV, Kumarasamy NA, Owens DK, Wang PJ, Hlatky MA. Circ Cardiovasc Qual Outcomes. 2011; 4 (1): 76-84
• Persistent racial disparities in survival after heart transplantation. Liu V, Bhattacharya J, Weill D, Hlatky MA. Circulation. 2011; 123 (15): 1642-9
• Physical activity in older subjects is associated with increased coronary vasodilation: the ADVANCE study. Nguyen PK, Terashima M, Fair JM, Varady A, Taylor-Piliae RE, Iribarren C, Go AS, Haskell WL, Hlatky MA, Fortmann SP, McConnell MV. JACC Cardiovasc Imaging. 2011; 4 (6): 622-9
• Racial variation in lipoprotein-associated phospholipase A₂ in older adults. Lee KK, Fortmann SP, Varady A, Fair JM, Go AS, Quertermous T, Hlatky MA, Iribarren C. BMC Cardiovasc Disord. 2011: 11 38
• Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ. Eur J Clin Invest. 2011; 41 (9): 1010-35
• The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). Hlatky M, J Am Coll Cardiol. 2011; 57 (7): 792-3
• The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction. Kessler DP, Kroch E, Hlatky MA. Am Heart J. 2011; 162 (3): 494-500.e2
• The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgery. Hlatky MA, Shilane D, Boothroyd DB, Boersma E, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kahler J, Lopes N, Pocock SJ, Rodriguez A, Serruys P, Sigwart U, Stables RH. J Thorac Cardiovasc Surg. 2011; 142 (4): 829-35
• The year in epidemiology, health services research, and outcomes research. Hlatky MA, Heidenreich PA. J Am Coll Cardiol. 2011; 57 (19): 1859-66
• What we can learn from a decision model: comment on "Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management". Hlatky MA, Arch Intern Med. 2011; 171 (7): 667-8
• Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Wheeler MT, Heidenreich PA, Froelicher VF, Hlatky MA, Ashley EA. Ann Intern Med. 2010; 152 (5): 276-86
• Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities. Sydow K, Fortmann SP, Fair JM, Varady A, Hlatky MA, Go AS, Iribarren C, Tsao PS. Clin Chem. 2010; 56 (1): 111-20
• Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. Assimes TL, Hólm H, Kathiresan S, Reilly MP, Thorleifsson G, Voight BF, Erdmann J, Willenborg C, Vaidya D, Xie C, Patterson CC, Morgan TM, Burnett MS, Li M, Hlatky MA, Knowles JW, Thompson JR, Absher D, Iribarren C, Go A, Fortmann SP, Sidney S, Risch N, Tang H, Myers RM, Berger K, Stoll M, Shah SH, Thorgeirsson G, Andersen K, Havulinna AS, Herrera JE, Faraday N, Kim Y, Kral BG, Mathias RA, Ruczinski I, Suktitipat B, Wilson AF, Yanek LR, Becker LC, Linsel-Nitschke P, Lieb W, König IR, Hengstenberg C, Fischer M, Stark K, Reinhard W, Winogradow J, Grassl M, Grosshennig A, Preuss M, Schreiber S, Wichmann HE, Meisinger C, Yee J, Friedlander Y, Do R, Meigs JB, Williams G, Nathan DM, MacRae CA, Qu L, Wilensky RL, Matthai WH, Qasim AN, Hakonarson H, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Knouff CW, Waterworth DM, Walker MC, Mooser VE, Marrugat J, Lucas G, Subirana I, Sala J, Ramos R, Martinelli N, Olivieri O, Trabetti E, Malerba G, Pignatti PF, Guiducci C, Mirel D, Parkin M, Hirschhorn JN, Asselta R, Duga S, Musunuru K, Daly MJ, Purcell S, Eifert S, Braund PS, Wright BJ, Balmforth AJ, Ball SG, Ouwehand WH, Deloukas P, Scholz M, Cambien F, Huge A, Scheffold T, Salomaa V, Girelli D, Granger CB, Peltonen L, McKeown PP, Altshuler D, Melander O, Devaney JM, Epstein SE, Rader DJ, Elosua R, Engert JC, Anand SS, Hall AS, Ziegler A, O'Donnell CJ, Spertus JA, Siscovick D, Schwartz SM, Becker D, Thorsteinsdottir U, Stefansson K, Schunkert H, Samani NJ, Quertermous T. J Am Coll Cardiol. 2010; 56 (19): 1552-63
• Repeat coronary revascularization procedures after successful bare-metal or drug-eluting stent implantation. Yock CA, Isbill JM, King SB, Hlatky MA. J Invasive Cardiol. 2010; 22 (1): 27-33
• Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. Terashima M, Nguyen PK, Rubin GD, Meyer CH, Shimakawa A, Nishimura DG, Ehara S, Iribarren C, Courtney BK, Go AS, Hlatky MA, Fortmann SP, McConnell MV. J Cardiovasc Magn Reson. 2010: 12 75
• The effect of obesity on quality of life in patients with diabetes and coronary artery disease. Hlatky MA, Chung SC, Escobedo J, Hillegass WB, Melsop K, Rogers W, Brooks MM. Am Heart J. 2010; 159 (2): 292-300
• The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. J Am Coll Cardiol. 2010; 56 (14): 1133-9
• Validation of the Stanford Brief Activity Survey: examining psychological factors and physical activity levels in older adults. Taylor-Piliae RE, Fair JM, Haskell WL, Varady AN, Iribarren C, Hlatky MA, Go AS, Fortmann SP. J Phys Act Health. 2010; 7 (1): 87-94
• A randomized trial of therapies for type 2 diabetes and coronary artery disease. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. N Engl J Med. 2009; 360 (24): 2503-15
• Characterizing the admixed African ancestry of African Americans. Zakharia F, Basu A, Absher D, Assimes TL, Go AS, Hlatky MA, Iribarren C, Knowles JW, Li J, Narasimhan B, Sidney S, Southwick A, Myers RM, Quertermous T, Risch N, Tang H. Genome Biol. 2009; 10 (12): R141
• Effect of race on the clinical outcomes in the bypass angioplasty revascularization investigation trial. Melsop K, Brooks MM, Boothroyd DB, Hlatky MA. Circ Cardiovasc Qual Outcomes. 2009; 2 (3): 186-90
• Evaluating use of coronary computed tomography angiography in the emergency department. Hlatky MA, J Am Coll Cardiol. 2009; 53 (18): 1651-2
• Insulin resistance independently predicts the progression of coronary artery calcification. Lee KK, Fortmann SP, Fair JM, Iribarren C, Rubin GD, Varady A, Go AS, Quertermous T, Hlatky MA. Am Heart J. 2009; 157 (5): 939-45
• Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients. Chan K, Moran J, Hlatky M, Lafayette R. Nephrol Dial Transplant. 2009; 24 (6): 1956-62
• The confirmatory trial in comparative-effectiveness research. Garber AM, Hlatky MA. N Engl J Med. 2009; 361 (15): 1498-9
• The dilemma of incidental findings on cardiac computed tomography. Hlatky MA, Iribarren C. J Am Coll Cardiol. 2009; 54 (16): 1542-3
• The year in epidemiology, health services research, and outcomes research. Hlatky MA, Heidenreich P. J Am Coll Cardiol. 2009; 54 (25): 2343-51
• The year in epidemiology, health services research, and outcomes research. Hlatky MA, Heidenreich PA. J Am Coll Cardiol. 2009; 53 (16): 1459-66
• Vision and creation of the American Heart Association pharmaceutical roundtable outcomes research centers. Peterson ED, Spertus JA, Cohen DJ, Hlatky MA, Go AS, Vickrey BG, Saver JL, Hinton PC. Circ Cardiovasc Qual Outcomes. 2009; 2 (6): 663-70
• A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Assimes TL, Knowles JW, Priest JR, Basu A, Borchert A, Volcik KA, Grove ML, Tabor HK, Southwick A, Tabibiazar R, Sidney S, Boerwinkle E, Go AS, Iribarren C, Hlatky MA, Fortmann SP, Myers RM, Kuhn H, Risch N, Quertermous T. Atherosclerosis. 2008; 198 (1): 136-44
• Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Assimes TL, Knowles JW, Priest JR, Basu A, Volcik KA, Southwick A, Tabor HK, Hartiala J, Allayee H, Grove ML, Tabibiazar R, Sidney S, Fortmann SP, Go A, Hlatky M, Iribarren C, Boerwinkle E, Myers R, Risch N, Quertermous T. Hum Genet. 2008; 123 (4): 399-408
• Expanding the orbit of primary prevention--moving beyond JUPITER. Hlatky MA, N Engl J Med. 2008; 359 (21): 2280-2
• Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD. Knowles JW, Assimes TL, Boerwinkle E, Fortmann SP, Go A, Grove ML, Hlatky M, Iribarren C, Li J, Myers R, Risch N, Sidney S, Southwick A, Volcik KA, Quertermous T. BMC Med Genet. 2008: 9 23
• Health-related quality of life following coronary artery bypass graft surgery in post-menopausal women. Covinsky KE, Lin F, Bittner V, Hlatky MA, Knight SJ, Vittinghoff E. J Gen Intern Med. 2008; 23 (9): 1429-34
• Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates. Burt JR, Iribarren C, Fair JM, Norton LC, Mahbouba M, Rubin GD, Hlatky MA, Go AS, Fortmann SP. Arch Intern Med. 2008; 168 (7): 756-61
• Incidental pulmonary nodules on cardiac computed tomography: prognosis and use. Iribarren C, Hlatky MA, Chandra M, Fair JM, Rubin GD, Go AS, Burt JR, Fortmann SP. Am J Med. 2008; 121 (11): 989-96
• Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. Kapoor JR, Gienger AL, Ardehali R, Varghese R, Perez MV, Sundaram V, McDonald KM, Owens DK, Hlatky MA, Bravata DM. JACC Cardiovasc Interv. 2008; 1 (5): 483-91
• Stents or surgery? New data on the comparative outcomes of percutaneous coronary intervention and coronary artery bypass graft surgery. Hlatky MA, Bravata DM. Circulation. 2008; 118 (4): 325-7
• Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Assimes TL, Knowles JW, Basu A, Iribarren C, Southwick A, Tang H, Absher D, Li J, Fair JM, Rubin GD, Sidney S, Fortmann SP, Go AS, Hlatky MA, Myers RM, Risch N, Quertermous T. Hum Mol Genet. 2008; 17 (15): 2320-8
• Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. Taylor-Piliae RE, Haskell WL, Iribarren C, Norton LC, Mahbouba MH, Fair JM, Hlatky MA, Go AS, Fortmann SP. J Cardiopulm Rehabil Prev. 2007 Jul-Aug; 27 (4): 227-32
• Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Knowles JW, Wang H, Itakura H, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS, Quertermous T, Hlatky MA. Am Heart J. 2007; 154 (6): 1052-8
• Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH. JAMA. 2007; 297 (22): 2502-14
• Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Ardigo D, Assimes TL, Fortmann SP, Go AS, Hlatky M, Hytopoulos E, Iribarren C, Tsao PS, Tabibiazar R, Quertermous T. Physiol Genomics. 2007; 31 (3): 402-9
• Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Itakura H, Sobel BE, Boothroyd D, Leung LL, Iribarren C, Go AS, Fortmann SP, Quertermous T, Hlatky MA. Am Heart J. 2007; 154 (6): 1059-64
• Ethnic differences in coronary artery calcium in a healthy cohort aged 60 to 69 years. Fair JM, Kiazand A, Varady A, Mahbouba M, Norton L, Rubin GD, Iribarren C, Go AS, Hlatky MA, Fortmann SP. Am J Cardiol. 2007; 100 (6): 981-5
• Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Hlatky MA, Ashley E, Quertermous T, Boothroyd DB, Ridker P, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS. Am Heart J. 2007; 154 (6): 1043-51
• Plasma leptin levels and coronary artery calcification in older adults. Iribarren C, Husson G, Go AS, Lo JC, Fair JM, Rubin GD, Hlatky MA, Fortmann SP. J Clin Endocrinol Metab. 2007; 92 (2): 729-32
• Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Hlatky MA, Quertermous T, Boothroyd DB, Priest JR, Glassford AJ, Myers RM, Fortmann SP, Iribarren C, Tabor HK, Assimes TL, Tibshirani RJ, Go AS. Am Heart J. 2007; 154 (6): 1035-42
• Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Al-Khatib SM, Sanders GD, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis A, Curtis J, Fain E, Gersh BJ, Gold MR, Haghighi-Mood A, Hammill SC, Healey J, Hlatky M, Hohnloser S, Kim RJ, Lee K, Mark D, Mianulli M, Mitchell B, Prystowsky EN, Smith J, Steinhaus D, Zareba W. Am Heart J. 2007; 153 (6): 941-50
• Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. Sanders GD, Al-Khatib SM, Berliner E, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis AB, Curtis JP, Domanski M, Fain E, Gersh BJ, Gold MR, Goldberger J, Haghighi-Mood A, Hammill SC, Harder J, Healey J, Hlatky MA, Hohnloser SH, Lee KL, Mark DB, Mitchell B, Phurrough S, Prystowsky E, Smith JM, Stockbridge N, Temple R. Am Heart J. 2007; 153 (6): 951-9
• Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese R, Kapoor JR, Ardehali R, Owens DK, Hlatky MA. Ann Intern Med. 2007; 147 (10): 703-16
• The high cost of implantable defibrillators. Hlatky MA, Mark DB. Eur Heart J. 2007; 28 (4): 388-91
• Cost-effectiveness as an outcome in randomized clinical trials. Hlatky MA, Owens DK, Sanders GD. Clin Trials. 2006; 3 (6): 543-51
• Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients. Stroupe KT, Morrison DA, Hlatky MA, Barnett PG, Cao L, Lyttle C, Hynes DM, Henderson WG. Circulation. 2006; 114 (12): 1251-7
• Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease. Hlatky MA, Melsop KA, Boothroyd DB. Am J Cardiol. 2006; 97 (12A): 59G-65G
• Improvement in quality of life after radiofrequency ablation. Hlatky MA, Wang P. Pacing Clin Electrophysiol. 2006; 29 (4): 341-2
• Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? Iribarren C, Go AS, Husson G, Sidney S, Fair JM, Quertermous T, Hlatky MA, Fortmann SP. J Am Coll Cardiol. 2006; 48 (9): 1800-7
• Self-rated health among women with coronary disease: depression is as important as recent cardiovascular events. Ruo B, Bertenthal D, Sen S, Bittner V, Ireland CC, Hlatky MA. Am Heart J. 2006; 152 (5): 921.e1-7
• The value of BNP testing. Hlatky M, Heidenreich P. Arch Intern Med. 2006; 166 (10): 1063-4
• Validation of a new brief physical activity survey among men and women aged 60-69 years. Taylor-Piliae RE, Norton LC, Haskell WL, Mahbouda MH, Fair JM, Iribarren C, Hlatky MA, Go AS, Fortmann SP. Am J Epidemiol. 2006; 164 (6): 598-606
• Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator. Hlatky MA, Sanders GD, Owens DK. Health Aff (Millwood). 2005 Jan-Feb; 24 (1): 42-51
• Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Reed SD, Anstrom KJ, Bakhai A, Briggs AH, Califf RM, Cohen DJ, Drummond MF, Glick HA, Gnanasakthy A, Hlatky MA, O'Brien BJ, Torti FM, Tsiatis AA, Willan AR, Mark DB, Schulman KA. Am Heart J. 2005; 149 (3): 434-43
• Cost effectiveness of cardiac resynchronization therapy. Hlatky MA, J Am Coll Cardiol. 2005; 46 (12): 2322-4
• Cardiovascular screening of athletes. Beckerman J, Wang P, Hlatky M. Clin J Sport Med. 2004; 14 (3): 127-33
• Evidence-based use of cardiac procedures and devices. Hlatky MA, N Engl J Med. 2004; 350 (21): 2126-8
• Health-related quality of life in patients with pulmonary arterial hypertension. Shafazand S, Goldstein MK, Doyle RL, Hlatky MA, Gould MK. Chest. 2004; 126 (5): 1452-9
• Underuse of evidence-based therapies. Hlatky MA, Circulation. 2004; 110 (6): 644-5
• Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Yock CA, Boothroyd DB, Owens DK, Garber AM, Hlatky MA. Am J Med. 2003; 115 (5): 382-9
• Depressive symptoms and health-related quality of life: the Heart and Soul Study. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. JAMA. 2003; 290 (2): 215-21
• Differences in medical care and disease outcomes among black and white women with heart disease. Jha AK, Varosy PD, Kanaya AM, Hunninghake DB, Hlatky MA, Waters DD, Furberg CD, Shlipak MG. Circulation. 2003; 108 (9): 1089-94
• Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty. Khan MA, Hlatky MA, Liu MW, Lin F, Rogers WJ, Shlipak MG. Am J Cardiol. 2003; 91 (8): 989-91, A7
• Quality of life and time trade-off utility measures in patients with coronary artery disease. Melsop KA, Boothroyd DB, Hlatky MA. Am Heart J. 2003; 145 (1): 36-41
• Does enrollment in a randomized clinical trial lead to a higher cost of routine care? Weiss JP, Parsons LS, Every NR, Weaver WD, Hlatky MA. Am Heart J. 2002; 143 (1): 140-4
• Economic endpoints in clinical trials. Hlatky MA, Epidemiol Rev. 2002; 24 (1): 80-4
• Economic evaluation in long-term clinical trials. Hlatky MA, Boothroyd DB, Johnstone IM. Stat Med. 2002; 21 (19): 2879-88
• Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Owens DK, Sanders GD, Heidenreich PA, McDonald KM, Hlatky MA. Am Heart J. 2002; 144 (3): 440-8
• Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries. Weiss JP, Saynina O, McDonald KM, McClellan MB, Hlatky MA. Am J Med. 2002; 112 (7): 519-27
• Life after a ventricular arrhythmia. Hsu J, Uratsu C, Truman A, Quesenberry C, McDonald KM, Hlatky MA, Selby J. Am Heart J. 2002; 144 (3): 404-12
• Management of ventricular arrhythmias in diverse populations in California. Alexander M, Baker L, Clark C, McDonald KM, Rowell R, Saynina O, Hlatky MA. Am Heart J. 2002; 144 (3): 431-9
• Medical economics and the assessment of value in cardiovascular medicine: Part I. Mark DB, Hlatky MA. Circulation. 2002; 106 (4): 516-20
• Medical economics and the assessment of value in cardiovascular medicine: Part II. Mark DB, Hlatky MA. Circulation. 2002; 106 (5): 626-30
• Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death. Heidenreich PA, Keeffe B, McDonald KM, Hlatky MA. Am Heart J. 2002; 144 (3): 422-30
• Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease. Every N, Hallstrom A, McDonald KM, Parsons L, Thom D, Weaver D, Hlatky MA. Am Heart J. 2002; 144 (3): 390-6
• Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995. McDonald KM, Hlatky MA, Saynina O, Geppert J, Garber AM, McClellan MB. Am Heart J. 2002; 144 (3): 413-21
• Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. Hlatky MA, Saynina O, McDonald KM, Garber AM, McClellan MB. Am Heart J. 2002; 144 (3): 397-403
• Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Hassan SA, Hlatky MA, Boothroyd DB, Winston C, Mark DB, Brooks MM, Eagle KA. Am J Med. 2001; 110 (4): 260-6
• Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, Owens DK. Ann Intern Med. 2001; 135 (10): 870-83
• The incidence of unrecognized myocardial infarction in women with coronary heart disease. Shlipak MG, Elmouchi DA, Herrington DM, Lin F, Grady D, Hlatky MA. Ann Intern Med. 2001; 134 (11): 1043-7
• The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. J Am Coll Cardiol. 2001; 38 (2): 478-85
• Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Cheng CH, Sanders GD, Hlatky MA, Heidenreich P, McDonald KM, Lee BK, Larson MS, Owens DK. Ann Intern Med. 2000; 133 (11): 864-76
• Prediction of risk for patients with unstable angina. Heidenreich PA, Go A, Melsop KA, Alloggiamento T, McDonald KM, Hagan V, Hastie T, Hlatky MA. Evid Rep Technol Assess (Summ). 2000; (31): 1-3
• Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI). Yock CA, Boothroyd DB, Owens DK, Winston C, Hlatky MA. Am Heart J. 2000; 140 (4): 556-64
• Quality of life after coronary revascularization in the United States and Canada. Bourassa MG, Brooks MM, Mark DB, Trudel J, Detre KM, Pitt B, Reeder GS, Rogers WJ, Ryan TJ, Smith HC, Whitlow PL, Wiens RD, Hlatky MA. Am J Cardiol. 2000; 85 (5): 548-53
• Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. Hlatky MA, Boothroyd DB, Brooks MM, Winston C, Rosen A, Rogers WJ, Reeder GS, Smith HC, Ryan TJ, Pitt B, Whitlow PL, Wiens RD, Mark DB. Am Heart J. 1999; 138 (2 Pt 1): 376-83
• Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of economic models in randomized clinical trials. Hlatky MA, Am Heart J. 1999; 137 (5): S41-6
• Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, Lee BK, Hlatky MA. JAMA. 1999; 281 (20): 1927-36
• Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioventricular nodal reentrant tachycardia. Larson MS, McDonald K, Young C, Sung R, Hlatky MA. Am J Cardiol. 1999; 84 (4): 471-3, A9
• Employment after coronary angioplasty or coronary bypass surgery in patients employed at the time of revascularization. Hlatky MA, Boothroyd D, Horine S, Winston C, Brooks MM, Rogers W, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB. Ann Intern Med. 1998; 129 (7): 543-7
• Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery. Hlatky MA, Bacon C, Boothroyd D, Mahanna E, Reves JG, Newman MF, Johnstone I, Winston C, Brooks MM, Rosen AD, Mark DB, Pitt B, Rogers W, Ryan T, Wiens R, Blumenthal JA. Circulation. 1997; 96 (9 Suppl): II-11-4; discussion II-15
• Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA. Ann Intern Med. 1997; 126 (1): 1-12
• Long-term cost-effectiveness of alternative management strategies for patients with life-threatening ventricular arrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM) Investigators. Hlatky MA, Boothroyd DB, Johnstone IM, Marcus FI, Hahn E, Hartz V, Mason JW. J Clin Epidemiol. 1997; 50 (2): 185-93
• Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB. N Engl J Med. 1997; 336 (2): 92-9
• Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Sim I, McDonald KM, Lavori PW, Norbutas CM, Hlatky MA. Circulation. 1997; 96 (9): 2823-9
• 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 6. Cost effectiveness of assessment and management of risk factors. Goldman L, Garber AM, Grover SA, Hlatky MA. J Am Coll Cardiol. 1996; 27 (5): 1020-30
• A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. N Engl J Med. 1996; 335 (17): 1253-60
• A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease. Sim I, Gupta M, McDonald K, Bourassa MG, Hlatky MA. Am J Cardiol. 1995; 76 (14): 1025-9
• Attitudes of women toward hormone therapy and prevention of heart disease. Pilote L, Hlatky MA. Am Heart J. 1995; 129 (6): 1237-8
• Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, Barbash G, White H, Simoons ML, Nelson CL. N Engl J Med. 1995; 332 (21): 1418-24
• Cost of initial therapy in the Electrophysiological Study Versus ECG Monitoring trial (ESVEM). Omoigui NA, Marcus FI, Mason JW, Hahn EA, Hartz VL, Hlatky MA. Circulation. 1995; 91 (4): 1070-6
• Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. Pilote L, Granger C, Armstrong PW, Mark DB, Hlatky MA. Med Care. 1995; 33 (6): 598-610
• Initial functional and economic status of patients with multivessel coronary artery disease randomized in the Bypass Angioplasty Revascularization Investigation (BARI). Hlatky MA, Charles ED, Nobrega F, Gelman K, Johnstone I, Melvin J, Ryan T, Wiens R, Pitt B, Reeder G. Am J Cardiol. 1995; 75 (9): 34C-41C
• Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals. Pilote L, Racine N, Hlatky MA. Arch Intern Med. 1994; 154 (10): 1090-6
• Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease. A prospective comparison study. Mark DB, Lam LC, Lee KL, Jones RH, Pryor DB, Stack RS, Williams RB, Clapp-Channing NE, Califf RM, Hlatky MA. Ann Intern Med. 1994; 120 (2): 111-7
• Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. Dudley RA, Harrell FE, Smith LR, Mark DB, Califf RM, Pryor DB, Glower D, Lipscomb J, Hlatky M. J Clin Epidemiol. 1993; 46 (3): 261-71
• Identification of patients with coronary disease at high risk for loss of employment. A prospective validation study. Mark DB, Lam LC, Lee KL, Clapp-Channing NE, Williams RB, Pryor DB, Califf RM, Hlatky MA. Circulation. 1992; 86 (5): 1485-94
• Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. Mark DB, Shaw L, Harrell FE, Hlatky MA, Lee KL, Bengtson JR, McCants CB, Califf RM, Pryor DB. N Engl J Med. 1991; 325 (12): 849-53
• Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. Nelson CL, Herndon JE, Mark DB, Pryor DB, Califf RM, Hlatky MA. Am J Cardiol. 1991; 68 (9): 973-5
• Using databases to evaluate therapy. Hlatky MA, Stat Med. 1991; 10 (4): 647-52
• Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. Honan MB, Harrell FE, Reimer KA, Califf RM, Mark DB, Pryor DB, Hlatky MA. J Am Coll Cardiol. 1990; 16 (2): 359-67
• Clinical judgment and therapeutic decision making. Hlatky MA, Califf RM, Harrell FE, Lee KL, Mark DB, Muhlbaier LH, Pryor DB. J Am Coll Cardiol. 1990; 15 (1): 1-14
• Feasibility and cost-saving potential of outpatient cardiac catheterization. Lee JC, Bengtson JR, Lipscomb J, Bashore TM, Mark DB, Califf RM, Pryor DB, Hlatky MA. J Am Coll Cardiol. 1990; 15 (2): 378-84
• Randomized comparison of the cost and effectiveness of iopamidol and diatrizoate as contrast agents for cardiac angiography. Hlatky MA, Morris KG, Pieper KS, Davidson CJ, Schwab SJ, Bashore TM. J Am Coll Cardiol. 1990; 16 (4): 871-7
• Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. Hlatky MA, Lipscomb J, Nelson C, Califf RM, Pryor D, Wallace AG, Mark DB. Circulation. 1990; 82 (5 Suppl): IV208-13
• Angina, myocardial ischemia and coronary disease: gold standards, operational definitions and correlations. Hlatky MA, Mark DB, Califf RM, Pryor DB. J Clin Epidemiol. 1989; 42 (5): 381-4
• Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, Bashore TM. Ann Intern Med. 1989; 110 (2): 119-24
• Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM. N Engl J Med. 1989; 320 (3): 149-53
• General anesthesia during percutaneous transluminary coronary angioplasty for acute myocardial infarction: results of a randomized controlled clinical trial. de Bruijn NP, Hlatky MA, Jacobs JR, Clements FM, Croughwell ND, Davis D, Flezzani P, Hill RF, Hinohara T, Kates RA. Anesth Analg. 1989; 68 (3): 201-7
• Physician utilization of laboratory procedures to monitor outpatients with congestive heart failure. Fleg JL, Hinton PC, Lakatta EG, Marcus FI, Smith TW, Strauss HC, Hlatky MA. Arch Intern Med. 1989; 149 (2): 393-6
• The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. Califf RM, Harrell FE, Lee KL, Rankin JS, Hlatky MA, Mark DB, Jones RH, Muhlbaier LH, Oldham HN, Pryor DB. JAMA. 1989; 261 (14): 2077-86
• Adoption of thrombolytic therapy in the management of acute myocardial infarction. Hlatky MA, Cotugno H, O'Connor C, Mark DB, Pryor DB, Califf RM. Am J Cardiol. 1988; 61 (8): 510-4
• Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Hlatky MA, Cotugno HE, Mark DB, O'Connor C, Califf RM, Pryor DB. Am J Cardiol. 1988; 61 (8): 515-8
• Exercise treadmill score for predicting prognosis in coronary artery disease. Mark DB, Hlatky MA, Harrell FE, Lee KL, Califf RM, Pryor DB. Ann Intern Med. 1987; 106 (6): 793-800
• Localizing coronary artery obstructions with the exercise treadmill test. Mark DB, Hlatky MA, Lee KL, Harrell FE, Califf RM, Pryor DB. Ann Intern Med. 1987; 106 (1): 53-5
• Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings. Slater DK, Hlatky MA, Mark DB, Harrell FE, Pryor DB, Califf RM. Am J Cardiol. 1987; 60 (10): 766-70
• Rethinking sensitivity and specificity. Hlatky MA, Mark DB, Harrell FE, Lee KL, Califf RM, Pryor DB. Am J Cardiol. 1987; 59 (12): 1195-8
• Exercise stress testing to screen for coronary artery disease in asymptomatic persons. Hlatky MA, J Occup Med. 1986; 28 (10): 1020-5
• Medical, psychological and social correlates of work disability among men with coronary artery disease. Hlatky MA, Haney T, Barefoot JC, Califf RM, Mark DB, Pryor DB, Williams RB. Am J Cardiol. 1986; 58 (10): 911-5
• Physician practice in the management of congestive heart failure. Hlatky MA, Fleg JL, Hinton PC, Lakatta EG, Marcus FI, Smith TW, Strauss HC. J Am Coll Cardiol. 1986; 8 (4): 966-70
• Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Papanicolaou MN, Califf RM, Hlatky MA, McKinnis RA, Harrell FE, Mark DB, McCants B, Rosati RA, Lee KL, Pryor DB. Am J Cardiol. 1986; 58 (13): 1181-7
• Prognostic significance of precordial ST-segment depression during inferior acute myocardial infarction. Hlatky MA, Califf RM, Lee KL, Pryor DB, Wagner GS, Rosati RA. Am J Cardiol. 1985; 55 (4): 325-9
• The yield of the routine admission electrocardiogram. A study in a general medical service. Moorman JR, Hlatky MA, Eddy DM, Wagner GS. Ann Intern Med. 1985; 103 (4): 590-5
• Tying clinical research to patient care by use of an observational database. Hlatky MA, Lee KL, Harrell FE, Califf RM, Pryor DB, Mark DB, Rosati RA. Stat Med. 1984 Oct-Dec; 3 (4): 375-87
• Diagnostic test use in different practice settings. A controlled comparison. Hlatky MA, Lee KL, Botvinick EH, Brundage BH. Arch Intern Med. 1983; 143 (10): 1886-9
• Natural history of patients with single-vessel disease suitable for percutaneous transluminal coronary angioplasty. Hlatky MA, Califf RM, Kong Y, Harrell FE, Rosati RA. Am J Cardiol. 1983; 52 (3): 225-9
• Diagnostic accuracy of cardiologists compared with probability calculations using Bayes' rule. Hlatky M, Botvinick E, Brundage B. Am J Cardiol. 1982; 49 (8): 1927-31
• Is renal biopsy necessary in adults with nephrotic syndrome. Hlatky MA, Lancet. 1982; 2 (8310): 1264-8
• The independent value of exercise thallium scintigraphy to physicians. Hlatky M, Botvinick E, Brundage B. Circulation. 1982; 66 (5): 953-9